Emergen-C
September 16th, 2014
June 2014: A superior court judge gave final approval of the settlement to this lawsuit. December 2013: A superior court
Browsing the "medicine" Tag
Walmart Equate Migraine
July 1st, 2014
April 2016: The Ninth Circuit Court of Appeals affirmed the district court’s dismissal concluding that the complaint failed to state
Heel, Inc.’s Pain Relief Products
June 30th, 2014
March 2014: A federal judge approved the settlement to this class-action lawsuit against Heel, Inc. October 2013: A federal judge
10 Second Trick to Help Prevent Your Heart Attack
January 31st, 2014
This ad has a number of things that should make you skeptical: 1. Clicking on the ad takes you to
Excedrin Migraine
January 22nd, 2014
In January 2014, a class-action lawsuit filed against Novartis Consumer Health over its marketing and pricing of Excedrin Migraine was
J&J to Pay $2.2 B to Settle Deceptive Marketing Charges
November 5th, 2013
Fine a deterrent, or just cost of doing business?
Vioxx
October 17th, 2013
In August 2013, a federal judge preliminarily approved a $23 million settlement to a class-action lawsuit filed against Merck Sharp
Earache Medicines
September 25th, 2013
The FDA sent warning letters to four earache medication makers demanding that the companies stop marketing their products, which the
Tylenol
September 23rd, 2013
A new in-depth report by ProPublica and This American Life is questioning Tylenol's safety and labeling.
Excedrin Migraine Pain Relief
August 21st, 2013
A reader submitted a tip concerning the pricing of Excedrin Migraine Pain Reliever versus Excedrin Extra Strength Pain Reliever.
Rebranded Drugs
August 13th, 2013
Some drugs are the same except for their names and packaging. For example: Sarafem, marketed as a treatment for Premenstrual
Illegally Sold Diabetes Treatments
August 6th, 2013
The FDA in July sent letters to 15 domestic and foreign companies telling them that their sale of diabetes treatments
Wyeth Agrees to $490 Million Payout for Unlawful Marketing
July 30th, 2013
Justice Department says company put profits over safety.
Boiron Children’s Coldcalm
June 10th, 2013
In June 2013, a settlement between Boiron, Inc. and consumers who filed a class-action lawsuit against it for allegedly falsely
SmartPractice
June 6th, 2013
According to a warning letter from the FDA, the Danish company, SmartPractice, promoted an allergic contact dermatitis test kit called
Potiga
June 5th, 2013
The FDA has warned consumers that anti-seizure medication Potiga can cause blue discoloration of the skin and pigment changes in
Doctor-Industry Financial Connections Revealed
March 21st, 2013
It's D-Day for the Sunshine Act. Find out who has been wining and dining your doctor.
Vytorin Cholesterol Pill
February 15th, 2013
Merck has agreed to settle two class-action lawsuits filed in 2008 against it and Schering-Plough Corp. (which Merck has since
Oregon Smacks Down Pfizer
January 9th, 2013
Oregon requiring Pfizer to get ads approved by FDA because of violations.
Misleading Drug Marketing Might Just Kill You
January 4th, 2013
Amgen, the world’s largest biotechnology company that made billions marketing its anemia drug Aranesp for unapproved uses, agreed to pay $762 million to settle off-use marketing charges.